MedPath

A study for comparison of two drugs combination of 0.0625% Levobupivacaine with Fentanyl and 0.1% Ropivacaine with Fentanyl for pain relief after a surgery named CRS+HIPEC

Phase 2
Conditions
Health Condition 1: K65-K68- Diseases of peritoneum and retroperitoneumHealth Condition 2: C569- Malignant neoplasm of unspecifiedovaryHealth Condition 3: C00-D49- Neoplasms
Registration Number
CTRI/2024/03/064211
Lead Sponsor
Rajiv Gandhi Cancer Institute and Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patient undergoing CRS with HIPEC for solid organ GI and Ovarian malignancy with peritoneal metastasis

Exclusion Criteria

Patient refusal or contraindication for epidural catheter. ASA physical status 3 and more.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compare VAS pain score to assess postoperative analgesia between two study groupsTimepoint: Every 6 hourly on postoperative day then every 12 hourly for next 3-4 days till epidural catheter is in situ
Secondary Outcome Measures
NameTimeMethod
Requirement of rescue analgesia doses and total volume of drug used for epidural infusionTimepoint: Every 6 hourly on postoperative day then every 12 hourly for next 3-4 days till epidural catheter is in situ
© Copyright 2025. All Rights Reserved by MedPath